Tumor Biology and Microenvironment Program Themes

Theme 1: To identify molecular, cellular determinants of malignancy (metastasis drivers)

Our investigators study key signaling pathways involved in tumorigenicity, tumor cell phenotypical plasticity, and tumor cell drug response (metastasis operatives).

Theme 1 Accomplishments 

Theme 2: To identify and exploit the underlying mechanisms of tumor metastasis (operatives)

Our investigators study the function and underlying mechanisms such as the extracellular proteolysis/signaling network that enable tumor cells to adapt to and eventually overcome the varying microenvironments.

Theme 2 Accomplishments 

Theme 3: To identify and exploit stromal reactivity and host immunity to tumor progression (host response to metastatic tumors)

Our investigators study the interaction of tumor cells with mesenchyme and innate immune cells. We also identify, evaluate and utilize adaptive cellular and humoral immune responses to develop immunotherapy approaches.

Theme 3 Accomplishments 

The Latest From Karmanos Cancer Institute

News

Miracle Five-Time Cancer Survivor Saved by Protons

Cancer has darkened Donna Ross’ door five times, and it all started with a lump in her left breast. “The cancer had spread to my lymph nodes,” Don...

Read More

Leading Cancer Research Centers Reinforce Importance of Safe and Effective Human Papillomavirus (HPV) Vaccination to Prevent Cancer

Today, the Barbara Ann Karmanos Cancer Institute , along with 62 National Cancer Institute (NCI)-Designated Cancer Centers with leading national o...

Read More

Karmanos Cancer Institute’s BMT, Hematology and Multiple Myeloma Teams Welcome New Physician

The Barbara Ann Karmanos Cancer Institute welcomes Bradley Rockwell, M.D. , transplant hematologist. Dr. Rockwell is a member of the Bone Marrow a...

Read More
News

105.9 KISS FM | Getting a Second Opinion at Karmanos

Listen Now

WJR | Karmanos Cancer Institute Continues Its Community Education Series

Listen Now

WXYT 97.1 The Ticket | ‘Get a Mammogram’

Listen Now